Arterial mediacalcinosis in patients with diabetes mellitus: etiopathogenetic and histopathological aspects
https://doi.org/10.14341/probl13360
Abstract
In a review of the generalized results of foreign and domestic studies on the development mechanism and pathogenesis of vascular calcification. The etiopathogenetic, pathophysiological and histomorphological features of mediacalcinosis, which reveal changes in the vascular bed in patients with DM, are considered. The role of risk factors for diseases, such as increased glycemia, changes in insulin levels, impaired lipid metabolism, obesity, arterial hypertension, CKD and aging, is indicated. The role of procalcifying and anticalcifying factors in colonic vascular remodeling is discussed. Identification of informative molecular markers and factors of CS will allow in the future to develop effective strategies for drug management of the risk of their progression and individual prevention programs to improve the quality and life expectancy in patients with cardiovascular diseases.
About the Authors
O. N. BondarenkoRussian Federation
Olga N. Bondarenko, MD, PhD
Moscow, Russia, 11, Dm. Uliyanova str., Moscow, 117292
M. V. Yaroslavceva
Russian Federation
Marianna V. Yaroslavceva, MD, PhD
Moscow
G. R. Galstyan
Russian Federation
Gagik R. Galstyan, MD, PhD, Professor
Moscow
N. G. Mokrysheva
Russian Federation
Natalia G. Mokrysheva, MD, PhD, Professor
Moscow
References
1. Bokeriya LA, Pokrovskij AV, Akchurin RS, Alekyan BG, Aphanova TV, Arakelyan VS. i dr. Nacional’nye rekomendacii po diagnostike i lecheniyu zabolevanij arterij nizhnih konechnostej. Moskva: 2019. Dostupno na: http://www.angiolsurgery.org/library/recommendations/2019/recommendations_LLA_2019.pdf (In Russ.)]
2. Hoek AG, Sabine R Zwakenberg SR, Petra J M Elders PJM. An elevated ankle-brachial index is not a valid proxy for peripheral medial arterial calcification. Atherosclerosis. 2021;323:13–19. doi: https://doi.org/10.1016/j.atherosclerosis.2021.03.010
3. Lanzer P, Hannan FM, Lanzer JD, et al. Medial Arterial Calcification. J Am Coll Cardiol. 2021;78(11):1145-1165. doi: https://doi.org/10.1016/j.jacc.2021.06.049
4. Nelson AJ, Raggi P, Wolf M, Gold AM, Chertow GM, Roe MT. Targeting Vascular Calcification in Chronic Kidney Disease. JACC Basic to Transl Sci. 2020;5(4):398-412. doi: https://doi.org/10.1016/j.jacbts.2020.02.002
5. Narula N, Dannenberg AJ, Olin JW, et al. Pathology of peripheral artery disease in patients with critical limb ischemia. J Am Coll Cardiol. 2018;72:2152–2163. doi: https://doi.org/10.1016/j.jacc.2018.08.002
6. Carlotta Onnis, Renu Virmani, Kenji Kawai, et al. Coronary Artery Calcification: Current Concepts and Сurrent Status. AHA Journals. 2024;149:Issue 3. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.065657
7. Melnikov MV, Barsukov AE, Zelinskiy VA, Apresyan AU. Aorta and major arteries calcinosis: pathobiological mechanisms and clinical significance. Regional blood circulation and microcirculation. 2012;11(2):4-10. (In Russ.)] doi: https://doi.org/10.24884/1682-6655-2012-11-2-4-10
8. Joshua D. Hutcheson and Claudia Goettsch. Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease. Circ Res. 2023;132(8):993–1012. doi: https://doi.org/10.1161/CIRCRESAHA.123.321760
9. Ricardo Villa-Bellosta. Vascular Calcification: A Passive Process That Requires Active Inhibition. Biology (Basel). 2024;13(2):111. doi: https://doi.org/10.3390/biology13020111
10. Mal’kov O.A., Govoruhina A.A., Burykin Yu.G. Rol’ kal’cifikacii v patogeneze vospalitel’noj reakcii arterial’noj stenki (na primere sosudov shei i golovy vzroslogo naseleniya). Zhurnal mediko-biologicheskih issledovanij. 2021;9(4):435-443 (In Russ.).] doi: https://doi.org/10.37482/2687-1491-Z081
11. Li M, Wang Z-W, Fang L-J, Cheng S-Q, Wang X, Liu N-F. Programmed cell death in atherosclerosis and vascular calcification. Cell Death Dis. 2022;13(5):467. doi: https://doi.org/10.1038/s41419-022-04923-5
12. Edmonds ME. Medial arterial calcification and diabetes mellitus. Zeitschrift für Kardiol. 2000;89(14):S101-S104. doi: https://doi.org/10.1007/s003920070107
13. Joon Myeong So, Ji Ho Park, Jin Gyeong Kim, et al. Medial Arterial Calcification and the Risk of Amputation of Diabetic Foot Ulcer in Patients With Diabetic Kidney Disease. J Korean Med Sci. 2023;38(21):e160. doi: https://doi.org/10.3346/jkms.2023.38.e160
14. Angela Beros , John Sluyter , Robert Keith Rhodes Scragg. Association of arterial stiffness and neuropathy in diabetes: a systematic review and meta-analysis. BMJ Open Diab Res Care. 2023;11:e003140. doi: https://doi.org/10.1136/bmjdrc-2022-003140
15. Young MJ, Adams JE, Anderson GF, Boulton AJM, Cavanagh PR. Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia. 1993; 36:615–621. doi: https://doi.org/10.1007/BF00404070
16. Sinha S, Munichoodappa CS, Kozak GP. Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases). Medicine (Baltimore) 1972;51:191–210. doi: https://doi.org/10.1097/00005792-197205000-00006
17. Clouse ME, Gramm HF, Legg M, Flood T. Diabetic osteoarthropathy. Clinical and roentgenographic observations in 90 cases. Am J Roentgenol Radium Ther Nucl Med. 1974;121:22–34
18. Forst T, Pfutzner A, Kann P, Lobmann RR, Schafer H, Beyer J. Association between diabetic-autonomic-C-fibre-neuropathy and medial wall calcification and the significance in the outcome of trophic foot lesions. Exp Clin Endocrinol Diabetes. 1995;103:94–98. doi: https://doi.org/10.1055/s-0029-1211335
19. Gentile S, Bizzarro A, Marmo R, de Bellis A, Orlando C. Medial arterial calcification and diabetic neuropathy. Acta Diabetol Lat. 1990;27:243–253. doi: https://doi.org/10.1007/BF02581336
20. Goebel FD, Fuessl HS. Mönckeberg’s sclerosis after sympathetic denervation in diabetic and non-diabetic subjects. Diabetologia. 1983;24:347–350
21. Harrison CV. The effect of sympathectomy on the development of experimental arterial disease. J Pathol. 1938;616:353–360. doi: https://doi.org/10.1002/path.1700480211
22. Wei Pan,Wei Jie, Hui Huang. Vascular calcification: Molecular mechanisms and therapeutic interventions. MedComm. 2023;4:e200. doi: https://doi.org/10.1002/mco2.200
23. Jeong-Hun Kang, Takahito Kawano, Masaharu Murata, Riki Toita. Vascular calcification and cellular signaling pathways as potential therapeutic targets. Life Sciences. 2024;336:1-20. doi: https://doi.org/10.1016/j.lfs.2023.122309
24. Yao H, Sun Z, Zang G, et al. Epidemiological Research Advances in Vascular Calcification in Diabetes. J Diabetes Res. 2021. doi: https://doi.org/10.1155/2021/4461311
25. Егшатян Л.В., Мокрышева Н.Г. Эктопическая кальцификация при хронической болезни почек Часть 1. Классификация и патогенез // Нефрология. — 2017. — Т. 21. — №4. — C. 30-39. doi: https://doi.org/10.24884/1561-6274-2017-21-4-30-39
26. Lanzhong W, Zhong C. High glucose environment promotes the expression of cell core proteoglycan in mouse vascular calcification. Prescription Drugs in China. 2019;17(5):13–15.
27. Lin X, Li S, Wang Y-J, et al. Exosomal Notch3 from high glucosestimulated endothelial cells regulates vascular smooth muscle cells calcification/aging. Life Sci. 2019;232:116582. doi: https://doi.org/10.1016/j.lfs.2019.116582
28. Kawakami R, Katsuki S, Travers R, et al. S100A9-RAGE Axis Accelerates Formation of Macrophage-Mediated Extracellular Vesicle Microcalcification in Diabetes Mellitus. Arterioscler Thromb Vasc Biol. 2020;40(8):1838-1853. doi: https://doi.org/10.1161/ATVBAHA.118.314087
29. Hero C, Svensson AM, Gidlund P, Gudbjornsdottir S, Eliasson B, EegOlofsson K. LDL cholesterol is not a good marker of cardiovascular risk in type 1 diabetes. Diabet Med. 2016;33(3):316–323. doi: https://doi.org/10.1111/dme.13007
30. Soedamah-Muthu SS, Chaturvedi N, Toeller M, et al. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care. 2004;27(2):530–537. doi: https://doi.org/10.2337/diacare.27.2.530.
31. Rita R. Kalyani, MD, MHS, FACP (Chair), Christopher P. Cannon, MD, Andrea L. Cherrington, MD, MPH and another Professional Practice Committee (PPC) of the American Diabetes Association (ADA). Professional Practice Committee Standards of medical care in diabetes—2018. Diabetes Care. 2018;41(Suppl 1): S3. doi: https://doi.org/10.2337/dc18-Sppc01
32. Nathan DM, DCCT EDIC Research Group. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014; 37(1):9-16. doi: https://doi.org/10.2337/dc13-2112
33. Jenkins AJ, Best JD, Klein RL, Lyons TJ. Lipoproteins, glycoxidation and diabetic angiopathy. Diabetes Metab Res Rev. 2004;20(5):349–68. doi: https://doi.org/10.1002/dmrr.491
34. Kadomceva LV, Zufarov A.A., N.V. Polikarpova N.V. Apolipoproteiny V i A1 kak markery riska razvitiya serdechno-sosudistyh oslozhnenij. Byulleten’ ekstrennoj mediciny. 2019;XII(5):67-70 (In Russ.)]
35. Kollerits B, Auinger M, Reisig V, et al. Lipoprotein(a) as a predictor of cardiovascular disease in a prospectively followed cohort of patients with type 1 diabetes. Diabetes Care. 2006;29(7):1661–3. doi: https://doi.org/10.2337/dc06-0546
36. Purnell JQ, Marcovina SM, Hokanson JE, et al. Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial. Diabetes. 1995;44(10): 1218–26
37. Chai S, Chen Y, Xin S, Yuan N, Liu Y, Sun J, Meng X, Qi Y. Positive Association of Leptin and Artery Calcification of Lower Extremity in Patients With Type 2 Diabetes Mellitus: A Pilot Study. Front Endocrinol (Lausanne). 2021;12:583575. doi: https://doi.org/10.3389/fendo.2021.583575
38. Proudfoot D, Davies JD, Skepper JN, Weissberg PL, Shanahan CM. Acetylated Low-Density Lipoprotein Stimulates Human Vascular Smooth Muscle Cell Calcification by Promoting Osteoblastic Differentiation and Inhibiting Phagocytosis. Circulation. 2002;106(24):3044-3050. doi: https://doi.org/10.1161/01.CIR.0000041429.83465.41
39. Wang J, Zhou JJ, Robertson GR, Lee VW. Vitamin D in Vascular Calcification: A Double-Edged Sword? Nutrients. 2018;10(5):652. doi: https://doi.org/10.3390/nu10050652
40. Bjornstad P, Maahs DM, Wadwa RP, et al. Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: The Coronary Artery Calcification in Type 1 Diabetes Study. J Clin Lipidol. 2014;8(6):576-583. doi: https://doi.org/10.1016/j.jacl.2014.08.008
41. Rajamannan NM, Evans FJ, Aikawa E, et al. Calcific Aortic Valve Disease: Not Simply a Degenerative Process. Circulation. 2011;124(16):1783-1791. doi: https://doi.org/10.1161/CIRCULATIONAHA.110.006767
42. Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE. Diabetes Accelerates Smooth Muscle Accumulation in Lesions of Atherosclerosis. Diabetes. 2001;50(4):851-860. doi: https://doi.org/10.2337/diabetes.50.4.851
43. Y. Xue, S. Lin, J. Y. Jia, and T. Yan, “Analysis of vascular calcification and its risk factors in uremic patients with diabetic nephropathy,” Journal of Jilin University (Medical Edition), vol. 5, pp. 946–951, 2010.
44. Iguchi T, Hasegawa T, Otsuka K, et al. Insulin resistance is associated with coronary plaque vulnerability: Insight from optical coherence tomography analysis. Eur Heart J Cardiovasc Imaging. 2014. doi: https://doi.org/10.1093/ehjci/jet158
45. Martín-Saladich Q, Simó R, Aguadé-Bruix S, et al. Insights into Insulin Resistance and Calcification in the Myocardium in Type 2 Diabetes: A Coronary Artery Analysis. Int J Mol Sci. 2023. doi: https://doi.org/10.3390/ijms24043250
46. Ong KL, McClelland RL, Rye KA, et al. The relationship between insulin resistance and vascular calcification in coronary arteries, and the thoracic and abdominal aorta: The multi-ethnic study of atherosclerosis. Atherosclerosis. 2014. doi: https://doi.org/10.1016/j.atherosclerosis.2014.07.015
47. Walrand S, Guillet C, Boirie Y, Vasson M-P. In vivo evidences that insulin regulates human polymorphonuclear neutrophil functions. J Leukoc Biol. 2004;76(6):1104-1110. doi: https://doi.org/10.1189/jlb.0104050
48. Cornell RP. Endogenous gut-derived bacterial endotoxin tonically primes pancreatic secretion of insulin in normal rats. Diabetes. 1985. doi: https://doi.org/10.2337/diab.34.12.1253
49. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, et al. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care. 2006;29(4):853-7. doi: https://doi.org/10.2337/diacare.29.04.06.dc05-1938
50. Mulnier HE, Seaman HE, Raleigh VS, Soedamah‐Muthu SS, Colhoun HM, Lawrenson RA. Mortality in people with Type 2 diabetes in the UK. Diabet Med. 2006;23(5):516-521. doi: https://doi.org/10.1111/j.1464-5491.2006.01838.x
51. Brel N.K., Gruzdeva O.V., Kokov A.N. Relationship between visceral obesity and coronary calcification in ischemic heart disease. Therapeutic archive. 2021; 93 (12): 1428–1434. doi: https://doi.org/10.26442/00403660.2021.12.201277]
52. Cosson E, Nguyen MT, Rezgani I, Tatulashvili S, Sal M, et al. Epicardial adipose tissue volume and coronary calcification among people living with diabetes: a cross-sectional study. Cardiovasc Diabetol. 2021;20(1):35. doi: https://doi.org/10.1186/s12933-021-01225-6
53. Li X, Yang H-Y, Giachelli CM. Role of the Sodium-Dependent Phosphate Cotransporter, Pit-1, in Vascular Smooth Muscle Cell Calcification. Circ Res. 2006;98(7):905-912. doi: https://doi.org/10.1161/01.RES.0000216409.20863.e7
54. Wang M, Li Z. Diabetes and vascular calcification. Chinese Journal of Arteriosclerosis. 2015;23(5):458-463
55. Savickij DV, Lin’kova NS, Kozhevnikova EO. SASP endoteliya i gladkomyshechnyh kletok sosudov: rol’ v patogeneze i terapii ateroskleroza. Molekulyarnaya medicina. 2022;20(4):9-15 (In Russ.).] doi: https://doi.org/10.29296/24999490-2022-04-02
56. Dyakov D.A., Akbasheva O.E. Oxidative stress and proteolysis system in type 2 diabetes. Diabetes mellitus. 2022;25(1):14-20. (In Russ.).] doi: https://doi.org/10.14341/DM12402
57. Anikin D.A., Solovyeva I.A., Demko I.V., Sobko E.A., Kraposhina A.Yu., Gordeeva N.V. Free-radical oxidation as a pathogenetic factor of metabolic syndrome. Obesity and metabolism. 2022;19(3):306-316. (In Russ.).] doi: https://doi.org/10.14341/omet12804
58. Daffu G, Del Pozo C, O’Shea K, Ananthakrishnan R, Ramasamy R, Schmidt A. Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond. Int J Mol Sci. 2013;14(10):19891-19910. doi: https://doi.org/10.3390/ijms141019891
59. Mustapha JA, Diaz-Sandoval LJ, Saab F. Infrapopliteal calcification patterns in critical limb ischemia: diagnostic, pathologic and therapeutic implications in the search for the endovascular holy grail. J Cardiovasc Surg (Torino). 2017;58:383–401
60. Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(S1). doi: https://doi.org/10.1002/dmrr.3266
Supplementary files
|
1. Figure 1. Echogram. B-mode. Calcification of the wall of the posterior tibial artery in a 73-year-old patient with type 2 diabetes for more than 20 years and chronic renal failure. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(377KB)
|
Indexing metadata ▾ |
|
2. Figure 2. Photographs. Calcified dorsal metatarsal artery of the foot in the 1 interphalangeal space (surgical material). | |
Subject | ||
Type | Исследовательские инструменты | |
View
(442KB)
|
Indexing metadata ▾ |
|
3. Figure 3. X-ray of the foot. Calcification of the arteries of the foot (indicated by arrows) | |
Subject | ||
Type | Исследовательские инструменты | |
View
(335KB)
|
Indexing metadata ▾ |
Review
For citations:
Bondarenko O.N., Yaroslavceva M.V., Galstyan G.R., Mokrysheva N.G. Arterial mediacalcinosis in patients with diabetes mellitus: etiopathogenetic and histopathological aspects. Problems of Endocrinology. 2025;71(1):50-59. (In Russ.) https://doi.org/10.14341/probl13360

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).